Moderna, Inc.
Long

Moderna (MRNA): mRNA Leader Trading at a 90% Discount

356
1️⃣ mRNA Technology Leadership: Moderna is revolutionizing vaccine development with its cutting-edge mRNA platform, positioning itself as a leader in the future of healthcare innovation.

2️⃣ Analyst Targets: With 28 ratings averaging $71.40 and highs of $85, Moderna offers over 60% upside from current levels.

3️⃣ Expanding Pipeline: Moderna’s broadening pipeline includes a variety of treatments, giving it multiple high-growth opportunities in the healthcare sector.

4️⃣ Technical Momentum: Moderna is holding key support at $43.85, with bullish signals of upward movement. The stock is primed for a breakout, supported by increasing volume and positive market sentiment.

📈 Trade Setup:

🎯 Take Profit 1: $50 (+14% potential gain)
🎯 Take Profit 2: $60 (+37% potential gain)
🏆 Take Profit 3: $70 (+59% potential gain)
📉 Stop Loss: $35 ⚠️ (For those with a conservative risk profile, but not necessary for long-term holders like myself)

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.